[The use of naniprus in patients with myocardial infarct complicated by acute left ventricular failure].
A study of 64 patients indicates Naniprus is a highly-effective drug for control left ventricular failure. Intravenous administration of naniprus (15-30 mg 2 times daily) is effective in the prophylaxis of recurrences of left ventricular failure in patients with myocardial infarction.
Ia V
IaV
Malinovskiĭ
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D009599:Nitroprusside / Q000008:administration & dosage* / Q000009:adverse effects; D012008:Recurrence; D013997:Time Factors; D016277:Ventricular Function, Left / Q000187:drug effects*
D009599:Nitroprusside